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Original Article
Origins and Progression of Adolescent
Endometriosis
Ivo Brosens, MD, PhD1, Caroline E. Gargett, PhD2,
Sun-Wei Guo, M.Med, PhD3, Patrick Puttemans, MD1,
Stephan Gordts, MD1, Jan J. Brosens, MD, PhD4,
and Giuseppe Benagiano, MD, PhD5
Abstract
Accumulating evidence indicates that adolescent endometriosis is common and often severe. Here we explore the possibility that
seeding of naive endometrial progenitor cells into the pelvic cavity early in life, that is, at the time of neonatal uterine bleeding or
soon after the menarche, results in more florid and progressive disease, characterized by highly angiogenic implants, recurrent
ectopic bleeding, and endometrioma formation. We discuss the potential intergenerational risk factors associated with early-
onset endometriosis and explore the molecular drivers of disease progression. Taken together, the available data suggest that an
increased focus on early-life events may help to identify young women at risk of severe, progressive endometriosis.
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Introduction
Effective management of endometriosis should be informed by
the likelihood of disease progression, especially in younger
women who have yet to achieve pregnancy. But what are the
conditions or risk factors associated with endometriosis pro-
gression? A recent study analyzed the laparoscopic findings in
500 adult women in an attempt to shed light on this issue.1
Unexpectedly, no correlation between the stage of endometrio-
sis and the age of the patient was observed. The authors con-
cluded that the revised American society for reproductive
medicine (rASRM) classification stage I or II endometriosis
is ‘‘equally likely to be present in women of all ages.’’ They
also concluded that stage III and IV disease is ‘‘not age depen-
dent.’’ Unfortunately, the study did not include a significant
number of adolescents with endometriosis. Nevertheless, the
findings illustrate that there is no obvious way to stratify
patients with endometriosis on the basis of whether the disease
is likely to progress, remain static, or regress.
This unsatisfactory state of affairs is not surprising as there
is no agreed definition of ‘‘progression’’ or even an understand-
ing of the natural history of endometriosis. In fact, the conclu-
sion reached by Savaris et al1 rests on the critical assumption
that the rASRM staging system can be employed to measure
disease progression. This conjecture is highly contentious. In a
3-year long prospective study of 643 consecutive laparosco-
pies, Koninckx et al2 evaluated the area, depth, and volume
of endometriotic lesions. The authors observed that the inci-
dence, area, and volume of subtle lesions decreased with age.
For typical lesions, however, these parameters increased with
age. More recently, the same group proposed a simple classi-
fication system, which scores separately the severity of super-
ficial, cystic, deep, and other lesions.3 If implemented, such a
scoring system would yield quantitative data that could be used
to predict the risk of progression for each type of lesion, thus
potentially resolving many of the uncertainties that currently
hamper more effective management of endometriosis.
Notwithstanding the dearth of evidence, it is not unreason-
able to consider that the time of onset of endometriosis in the
life cycle could be an important determinant of the risk of
disease progression.4 In this position paper, we explore the pos-
sibility that early-onset or adolescent endometriosis is distinct
from, and more progressive than, adult endometriosis. We wish
to stress that our hypothesis is largely based on biological
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plausibility, rather than conclusive clinical evidence. Our aim is
to pique interest into neglected early-life events that may shape
the course of endometriosis during the reproductive years.
Origins of Early-Onset Endometriosis
Over the last few years, we have reinterpreted and summarized
the largely historical literature on neonatal uterine bleeding
(NUB) and concluded that endometrial breakdown and bleed-
ing soon after birth likely represent an important risk factor for
early-onset endometriosis.5-10 This hypothesis is based on a
series of intriguing observations. Like menstruation, NUB is
triggered by the rapid fall in circulating progesterone levels in
the first few days after birth. However, unlike menstruation,
NUB affects only 5% of newborn girls.11-14 The reason for this
discrepancy lies in the ontogeny of steroid hormone responses
in the fetal endometrium. Rosa15 studied fetal sexual develop-
ment in a series of 31 female fetuses, aged between 4½ months
gestation to term. Although formation of the fetal endometrium
is completed by 4½ months, both the stromal and glandular
compartments were found to be inactive. Evidence of an estro-
genic response was observed between 5 to 7½ months of gesta-
tion. By the second half of the eighth month, progesterone-
dependent changes in the glandular compartment became
apparent, exemplified by coiled glands, apocrine secretions,
and glycogen enclaves. In fact, these observations led to the
concept that the fetal endometrium, over a period of 4 months
(from the fifth month till term), mimics the changes observed in
a normal 28-day ‘‘menstrual’’ cycle. There are, however, sig-
nificant differences between the sequential estrogen and pro-
gesterone actions in the fetal endometrium and those of the
menstrual cycle, including the poorly developed glands in fetal
endometrium and the absence of the decidual changes in
stroma. On the other hand, the pioneering yet largely ignored
postmortem study of Ober and Bernstein16 documented a
broader spectrum of progesterone responses in uteri from neo-
nates who had died soon after birth. This study demonstrated
that decidual transformation and endometrial shedding do
occur in the neonatal uterus, but the incidence is low, approx-
imately 5%. However, occult bleeding, detectable using differ-
ent laboratory techniques, is more common and affects
approximately 25% of babies.12,13
Neonatal uterine bleeding is today viewed as a clinically
irrelevant event. This was not always the case. Several large
clinical studies carried out in the 1960s and 1970s identified
potential risk factors for NUB.11-14 As these studies preceded
ultrasound dating of pregnancy, the findings should be inter-
preted with caution. Nevertheless, the collective evidence indi-
cates that postmaturity is a major risk factor for NUB.14 More
surprisingly, NUB was also found to be strongly associated
with preeclampsia and low birth weight. There was also a
suggestion of an association between NUB and Rhesus or ABO
incompatibility, although this is contentious.10,11 Nevertheless,
a recent epidemiological study found that Rh-negative women
are twice as likely to develop endometriosis.17 Chromosome
1p, which contains the genes coding for the Rh factor, also
harbors an endometriosis susceptibility region near the WNT4
gene.18 In this respect, a recent metanalysis by Rahmioglu
et al18 evaluated 8 genome-wide association studies (GWAS)
in an attempt to identify common genetic variants in endome-
triosis. The investigators concluded that there is a remarkable
consistency in endometriosis GWAS results across studies,
with little evidence of population-based heterogeneity. They
also stressed the importance for future studies to include
detailed sub-phenotype information. We believe that this rec-
ommendation is particularly appropriate for GWAS studies.
Functional studies in relevant tissues are needed to understand
the effect of the variants on downstream biological pathways.
At present, Sampson theory developed in the 1920s remains
the most widely accepted theory on the origins of endometrio-
sis.19 His hypothesis is based on the tacit assumption that men-
strual effluent contains viable cells from the superficial
endometrium. It is now well established that menstrual blood
indeed comprises a mix of endometrial mesenchymal stem
cells (eMSCs) and stromal fibroblasts, although epithelial and
epithelial progenitor cells may have been overlooked.20,21
These cells presumably first attach and then breach the perito-
neum, a notion increasingly supported by experimental
data.22,23 Interestingly, Arcellana et al24 provided evidence of
the initial stages of endometriosis formation in a female infant
with menstruation-like bleeding. The baby had McKusick-
Kaufman syndrome and died approximately 8 hours after birth.
Postmortem examination revealed an intact transverse vaginal
septum with hydrocolpos containing 200 mL of cloudy fluid.
Examination of the peritoneal cavity revealed hemorrhagic
endometrial reflux and implantation of epithelial fragments
on the bowel serosa as well as adhesions around the ovaries
and upper uterus. These findings are consistent with the
implantation model of endometriosis. It seems not unreason-
able to assume that eMSCs and epithelial progenitor cells have
the ability to quickly implant in the pelvis during the early
neonatal period. The relatively long cervix and thick cervical
secretions in the neonate may even facilitate retrograde seeding
of endometrial progenitor cells.6,7 Inherent to endometrial
stem/progenitor cells is their ability to remain dormant for
many years.25 Hence, it is not inconceivable that endometrial
progenitor cells seeded in the pelvis soon after birth remain
quiescent until rising estrogen production that precedes the
menarche stimulates angiogenesis and promotes the formation
of hemorrhagic endometriotic lesions.7,26 By extension, it can
be argued that the earlier the menarche takes place in the life
cycle, the higher the risk may be of inimical endometriotic
disease because of seeding of less committed and more multi-
potent endometrial stem/progenitor cells. Whether or not NUB
in turn is associated with early menarche, possibly reflecting
increased steroid hormone responsiveness of the endometrium,
is not known.
Intergenerational Risk Factors
There is increasing awareness that reproductive disorders prior
to conception may increase the risk of obstetrical complications
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in pregnancy.27 However, if and how pregnancy disorders
impact on the reproductive function of the offspring remains
unknown. Arguably, the reportedly strong association between
maternal preeclampsia and NUB10,11 warrants further investi-
gation as it raises the possibility that in utero stress in preg-
nancy accelerates the process of hormonal responsiveness of
the fetal endometrium and thus the risk of NUB. Furthermore,
it is not inconceivable that maternal preeclampsia also facil-
itates subsequent ectopic implantation of endometrial tissue in
the newborn. This conjecture is based on the emerging role of
platelets in the pathogenesis of endometriotic lesions.28 In a
mouse model of endometriosis, aggregation of platelets at ecto-
pic implants coincides with heightened vascular endothelial
growth factor (VEGF) expression and increased microvessel
formation. Furthermore, coculturing of endometriotic stromal
cells with platelets increases proliferation and stimulates the
expression of key factors, including estrogen receptor-b,
VEGF, cyclooxygenase 2, and gelatinase (Matrix-Metallo-
Peptidase-9).28 It is well established that preeclampsia influences
the expression of surface glycoproteins on not only maternal but
also neonatal platelets.29,30 Klein et al31 demonstrated that plate-
lets from newborn of preeclamptic mothers exhibit increased
reactivity, even in response to weak activators such as adenosine
diphosphate. Hence, it would be informative to examine the
responses of endometriotic stromal cells to cord blood platelets
isolated from preeclamptic versus control pregnancies. In addi-
tion, in view of a possible association between exposure to certain
environmental toxic agents and endometriosis,32 it is also con-
ceivable that in utero or postnatal exposure to endocrine disrup-
tors or xeno-estrogens, like bisphenol A and S, may be permissive
for early-onset endometriosis.
Adolescent Endometriosis: Hemorrhagic
Lesions and Endometrioma Formation
It has been suggested that endometriosis is a physiological
process, unless recurrent bleeding in ectopic implants causes
disease progression by inducing adhesions, fibrosis, and the
formation of endometriotic cysts.33 Adolescent endometriosis
is typically characterized by red hemorrhagic peritoneal
lesions and, in severe cases, by large ovarian endometriomas
(Figure 1). Gogacz et al34 described a case of ovarian endome-
trioma in a prepubertal girl showing typical features of endo-
metrial tissue with hemosiderin-loaded macrophages lining the
ovarian cortex. Tong et al35 described a series of 94 young girls
with Herlyn-Werner-Wu¨nderlich syndrome (HWWS), defined
by the presence of a uterus didelphus with an obstructed hemi-
vagina and ipsilateral renal agenesis or dysplasia. Endometrio-
sis was found at laparoscopy or laparotomy in 18/94 (19%)
patients; and all had cystic ovarian endometriosis. The median
time between menarche and onset of cyclic pelvic pain was
1 year (range 0-16 years), while the median time between
menarche and the diagnosis of pelvic endometriosis was 3 years
(range 1-16 years). The age of onset of endometriosis (18 +
5.4 years) was much earlier than the age of diagnosis of
HWWS. The presence of typical endometriomas in these girls
supports the notion that adolescent endometriosis is indeed
caused by retrograde shedding of eMSCs. Notably, MSCs iso-
lated from ectopic lesions show greater invasiveness and
migration ability as well as the capacity to stimulate neoangio-
genesis compared to those in eutopic endometrium.26 These
cellular differences may relate to the distinct niche environ-
ment in ectopic sites36 or, alternatively, reflect the early-life
origins of ectopic eMSCs.7
Until recently, the presence of an endometrioma in adoles-
cents was considered the exception. Wright and Laufer37
reported on a 19-year-old woman with bilateral endometriomas
and concluded: ‘‘Endometriomas are rare in adolescents. There
are no case reports in the literature to date’’ and ‘‘most endo-
metriosis in adolescence is of an early stage.’’ Yet, a literature
review of recent studies shows that a substantial proportion of
girls with early-onset endometriosis have a severe (rASRM
stage III or IV) disease at laparoscopy and that the severity is
largely caused by the presence of ovarian endometriomas
(Table 1).35,38-42 A recent study of 86 adolescents and young
women (aged  22 y) attending a tertiary referral center for
surgery showed that 66 (77%) had stage I or II disease and
20 (23%) had stage III or IV, of whom 14 (70%) had endome-
triomas.41 Rectovaginal endometriosis was found in 1 case and
diaphragmatic and pulmonary disease in another case. The
authors concluded that the main reason for advanced stage
endometriosis in this age-group was the presence of ovarian
endometriomas, rather than extensive adhesive disease.
Finally, another study of 55 adolescents with endometriosis,
aged between 12 and 19 years, reported stage III/IV disease
in 24 (44%) girls, including 18 (33%) patients with endome-
triomas and 6 (11%) with deep infiltrating endometriosis.42
Taken together, these studies show that adolescent endometrio-
sis is neither rare nor mild. Instead, early-onset endometriosis is
often characterized by florid hemorrhagic lesions and endome-
trioma formation, an observation that further supports the con-
jecture that the implants must have been established prior or
soon after to the onset of the menarche.
The Progressive Phenotype of Ovarian
Endometriomas
In a seminal study of ovaries with endometriomas in situ
obtained at the time of hysterectomy, Hughesdon43 described
degenerative changes in the cortex lining the cyst and the
underlying interstitial tissue. In most cases, the ovarian cortex
was no longer recognizable and seems to have been replaced by
a darkly stained connective tissue. However, the occasional
presence of follicles and continuity with unaltered cortex con-
firmed that the ovarian surface of the endometrioma was in fact
cortex partly or completely transformed into fibromuscular tis-
sue. According to Hughesdon,43 the presence of an inner cortex
implies that ectopic endometrium does not erode its way into
the ovary, rather the cortex becomes invaginated. In agreement,
ovarioscopy, that is, endoscopic inspection of an ovarian cyst,
often reveals a marble-white or pigmented invaginated
cortex lined by endometrial-like tissue in recently formed
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Figure 1. Vascularity of endometriotic lesions assessed by transvaginal hydrolaparoscopy. More than 65% of underwater close-ups of so called
‘‘atypical’’ or ‘‘subtle’’ peritoneal implants (top row), active endometriotic implants within the opened endometrioma (middle row), or con-
necting and nonconnecting endometriotic adhesions (bottom row) show a complex vascular tangle of newly formed capillaries, illustrating the
extensive neovascularization that accompanies the development of endometriosis. This information is lost at conventional laparoscopy due to
the increased intra-abdominal pressure induced by the pneumoperitoneum. Moreover, this hypervascularization offers a second target, beside
the implants themselves, for electro- or laser coagulation, thus interrupting hormonal exposure and oxygen supply to the lesions.
4 Reproductive Sciences
 by guest on May 5, 2016rsx.sagepub.comDownloaded from 
endometriomas, which is gradually replaced by dark pigmented
fibrotic tissue in older patients (Figure 2). In support of these
findings, transvaginal color Doppler sonography demonstrated
decreased interstitial flow and significantly higher resistance
indices in patients with ovarian endometriomas when com-
pared to controls presenting with a benign ovarian tumor.44
Smooth muscle metaplasia (SMM), detectable by positive
staining for alpha-smooth muscle actin, is a common feature of
ovarian endometriomas.45 As is the case in other tissues, SMM
and tissue fibrosis are the consequence of repetitive tissue
injury, bleeding, and repair. Platelets aggregate in ovarian cysts
and promote epithelial-mesenchymal transition, characterized
by acquisition of specialized smooth muscle cell markers, such
as desmin, oxytocin receptor, and smooth muscle myosin
heavy chain.28 Guo et al46 found that fluid from endometriomas
from older patients also contains significantly higher concen-
tration of total bilirubin, ferritin, and free iron when compared
to younger women. In addition, older lesions have significantly
more collagen content, higher adhesion scores, and contain
more viscous fluid. Taken together, these data support the
notion that the changing nature of endometriomas with age
reflects the impact of repeated injuries and repair, resulting
in largely fibrotic, nonprogressive lesions that are resistant to
hormonal treatment.46 Similar observations can also be seen in
adenomyosis, a closely related disorder.47
A recent review charted the potential cellular and molecular
mechanisms by which endometriomas could damage the
ovary.48 Endometriomas contain free iron, reactive oxygen
species, proteolytic enzymes, and inflammatory molecules in
concentrations that are 10 to 100 times higher than those in
peripheral blood. The noxious cyst content triggers a chronic
stress response in endometrial cells lining the endometrioma,
thereby altering gene expression and potentially damaging
DNA. The physical barrier between the cyst contents and the
interstitial ovarian tissue is a thin wall composed of the over-
stretched ovarian cortex or fibro-reactive tissue. Reactive
Table 1. Incidence of Ovarian Endometrioma and Deep or Rectovaginal Endometriosis in Adolescents or YoungWomenWith Advanced Stage
Pelvic Endometriosis.
Normal GT Age (years) Stage III-IV (n) Endometrioma Deep or RV
Vicino38  21 26 26 (100%) 0 (0%)
Yang39  21 48 40 (83%) 18 (40%)
Lee40  20 35 35 (100%) 0 (0%)
Smorgick41  22 20 14 (70%) 1 (5%)
Audebert42 12-19 24 18 (75%) 6 (25%)
GT obstruction Age Number Endometrioma Deep or RV
Yang39 21 15 14 (93%) 2 (13%)
Tong35
Complete < 20 10 10 (100%) 0 (0%)
Incomplete < 37 8 8 (100%) 0 (0%)
Abbreviations: GT: genital tract; Deep or RV: deep or rectovaginal endometriosis.
Figure 2. Assessment of ovarian endometriomas by ovarioscopy. A, In younger women, the wall of the endometriotic cyst has the same
marble-white or yellowish appearance as the outer cortex and is lined by a thin highly vascularized mucosa. B, By contrast, the lining of older
cysts typically appears darker, fibrotic, and devascularized.
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oxygen species can permeate to the surrounding tissues and
activation of proteolytic enzymes promotes remodeling of the
normal ovarian cortex and contributes to the generation of
fibrous tissue. The lower follicular density observed in the endo-
metrioma bed may be primarily the result of vascular sclerosis.
Finally, iron and ferritin concentrations are also significantly
higher in the peritoneal fluid of patients with endometriosis.49
In a mouse model, iron overload did not affect the establishment
of ectopic lesions but promoted cell proliferation and thus con-
tributed to the further growth of endometriotic lesions.50
Perspectives
While both NUB and cyclic menstruation share the core
concept that endometrial tissue breakdown following
progesterone-dependent decidualization enables implantation
of endometrial cells at ectopic sites, a number of putatively
distinguishing features should be considered. First, it is not
unreasonable to assume that neonatal eMSCs and endometrial
epithelial progenitor cells are longer lived, less committed, and
more multipotent than their adult counterparts. Conversely, the
potential of more differentiated or aging endometrial progeni-
tor cells seeded later in life to form hemorraghic endometriotic
lesions may be greatly diminished. Second, increased platelet
activation, especially in the context of preeclamptic pregnan-
cies, and a more naive immune system may further increase the
implantation density of endometrial stem/progenitor cells at
NUB compared to cyclic menstruation. Furthermore, pro-
longed enforced dormancy of these implants, from birth until
the menarche, may lead to selection of more aggressive lesions.
Bone marrow-derived cells may also be recruited to the devel-
oping lesions, promoting their progression and rapid develop-
ment soon after the menarche.51 As illustrated by the changing
nature of endometriomas, the angiogenic potential of the ecto-
pic implants is likely the primary driver of disease progression
with recurrent tissue injury, bleeding, and repair ultimately
resulting in largely fibrotic lesions.
Our 2-pronged origins of endometriosis hypothesis should
focus and advance the search for discriminatory cellular or
molecular markers that identify patients at risk of progressive
disease. This is an obligatory step to make precision medicine
in endometriosis a reality. Systematic recording of the presence
or absence of NUB in neonatal records has the potential to
significantly change our understanding of the origins of endo-
metriosis. Unfortunately, even if this simple measure is put in
place, it will take decades for prospective studies to prove or
disprove a link between NUB and endometriosis.
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